Abuse-Deterrent Opioids: Changing Paradigms in Comprehensive Pain Management

PRE-ACTIVITY SURVEY Release Date: Thursday May 2, 2019 Expiration Date: Saturday May 2, 2020

EDUCATIONAL OVERVIEW

Opioids play an important role in the management of moderate-to-severe pain and the use of opioid medications has steadily increased over the past few decades. With the growing use of opioids, there has been a correlating increase in opioid abuse, diversion, and misuse. To combat opioid abuse, a multifaceted approach is needed that can include the use of abuse-deterrent formulations (ADFs). ADFs can employ various technologies, such as physical/chemical barriers to prevent crushing or extraction, as well as the use of an agonist/antagonist combination that neutralizes the opioid effect if manipulated. Though the use of ADFs can be an important component in ensuring the responsible use of opioids, the incorporation of ADFs into pain management decisions will require a thorough understanding of the available formulations, including the technologies utilized, dosing for optimal effectiveness, and safety considerations. This program will review the burden of opioid abuse in today’s society while providing an overview of the current and emerging ADF technologies. This program will also highlight the role of pharmacists in guiding pain management decisions as part of an interprofessional healthcare team.

TARGET AUDIENCE

This continuing pharmacy education activity is planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare systems, community pharmacies, outpatient clinics, pain management clinics, managed care organizations, long-term care facilities, and academia. This program targets pharmacists who are interested in pain management, new drug therapies, and improving the care of patients with chronic pain.

LEARNING OBJECTIVES

Learners participating in the program will be able at its conclusion to:

Identify the role of pharmacists in reducing risk of opioid use through a multifaceted approach that includes interprofessional communication, patient education, and pharmaceutical selection
Describe abuse-deterrent technologies utilized in current and emerging opioid medications aimed at reducing patient risk
Evaluate the role of abuse-deterrent opioids as part of comprehensive pain management plans for patients with chronic pain

EDUCATIONAL FORMAT

This Online Presentation is based on the Satellite Symposium presented at APhA2019 Annual Meeting. The following topics are covered:

The Consequences of Opioid Abuse

Balancing Risks and Benefits of Opioids

Role of Abuse-Deterrent Formulations in Pain Management

Note: If you have received credit for attending the live program by the same name, you are not eligible to apply for credit for this online version.

Please click here for additional resources.

FACULTY

	Gregory L. Holmquist, PharmD, CPE Certified Pain Educator Pain Management / Palliative Care Pharmacist Specialist Hospice / Palliative Care Consultant Chronic Non-cancer Pain Consultant LTC Elderly Pain Consultant Private Pain Management Consultant Palliative Care Strategies Everett, WA

Pharmacists

Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credits for participating in this activity.

ACPE UAN: 0473-9999-19-003-H01-P
Activity type: Application-based

For questions regarding the accreditation of this activity, please contact us at info@jointsponsor.com

Method of Participation and Instruction for Credit

Review the entire CPE information including target audience, learning objectives, and disclosures.
Review the activity in its entirety.
Complete the Online Post Test, Evaluation, and Credit Application form
Please note that to receive credit you must achieve a score of at least 70%.
Credits will be uploaded to CPE Monitor within 4 weeks of activity completion and you will be able to access your credits from the profile you set up with NABP.

Disclosure of Conflicts of Interest

In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.

Disclosures
Gregory Holmquist, PharmD has relevant financial relationships with the following commercial interests:
Speakers Bureau: Daiichi-Sankyo, Inc.
Dr. Holmquist does not discuss off-label uses of any products.

No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Fee
There is no fee to participate in this activity.

Hardware/Software Requirements
Microsoft Internet Explorer, Mozilla Firefox, Apple Safari or Google Chrome with the QuickTime Plug-in
Note: Please disable any “pop-up blocker” features.

Software/Hardware
Adobe® Reader version 7 or above to view PDF files (If you do not have Adobe® Reader, you can download it for free from Adobe.com)
Adobe Flash Player version 10 or above to view multimedia content (If you do
not have Adobe Flash Player, you can download it for free from Adobe.com)

Connection Speed
Cable, DSL, or better of at least 300 kbps

System Check
Please e-mail any questions or concerns to info@vemcomeded.com.

Privacy Policy
http://www.vemcomeded.com/privacy.asp

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support

This activity is supported by an educational grant from Daiichi-Sankyo, Inc.

By clicking on the activity icon below, I acknowledge that I have read the entire CPE information.